Company Filing History:
Years Active: 2021
Title: Romain Bertrand: Innovator in Glucagon Receptor Agonists
Introduction
Romain Bertrand is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of medical imaging through his innovative work on glucagon receptor agonists.
Latest Patents
Romain Bertrand holds a patent for "Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes." This invention relates to exendin-4 peptide analogues that selectively bind and activate the glucagon receptor. These analogues include a chelating moiety capable of binding a metal ion, which can be utilized in PET imaging.
Career Highlights
Romain Bertrand is associated with Antaros Medical AB, where he applies his expertise in developing advanced medical imaging techniques. His work focuses on enhancing the capabilities of imaging technologies to improve diagnostic processes.
Collaborations
Romain collaborates with esteemed colleagues such as Torsten Haack and Oliver Plettenburg, contributing to a dynamic research environment that fosters innovation.
Conclusion
Romain Bertrand's work exemplifies the intersection of innovation and medical technology, particularly in the realm of glucagon receptor agonists. His contributions are paving the way for advancements in imaging techniques that could significantly impact patient care.